Reproductive Freedom for All
Coverage of Reproductive Freedom for All in the Nexus archive.
- Abortion matters to voters — but it may not mobilize them, poll suggests
A survey in Arizona, Michigan, and Nevada found that 80% of voters consider protecting abortion access important, but concerns about Medicaid cuts and taxes are ranked higher. The study suggests abortion may not be the primary mobilizing issue for voters despite its significance in candidate selection.
- Reproductive Freedom for All announces six-figure Michigan canvassing investment
Reproductive Freedom for All announced a six-figure investment in Michigan canvassing efforts for the November midterms, focusing on mobilizing voters in the 'My Body. My Ballot.' campaign. The organization highlighted targets like Michigan's 7th Congressional District and criticized Republican candidates for supporting Medicaid cuts and limiting abortion access.
- Abortion rights group launches multi-million dollar midterm campaign
A major reproductive rights group is launching a multi-million-dollar midterm election campaign to mobilize voters and flip key battleground districts by electing pro-abortion Democrats. Reproductive Freedom For All is investing $23.5 million this year, the most it has ever spent on a midterm election. The effort will focus on persuading 'independents, soft Republicans, and split-ticket voters'.
- Bethel, Warren hang on to Georgia Supreme Court seats
Incumbent Georgia Supreme Court justices Charlie Bethel and Sarah Warren retained their seats after defeating Democratic-backed challengers in a nonpartisan primary election. Bethel narrowly held his position with 51.1% of the vote, while Warren led with nearly 60% of the vote, both emphasizing a commitment to a nonpartisan judiciary.
- Abortion pill rulings bring the issue back to the forefront in a midterm election year
Recent court rulings on abortion pill access have brought the issue back into the spotlight ahead of the midterm elections, with advocates on both sides hoping to sway voters. The rulings have restricted and then temporarily restored access to the drug mifepristone, causing uncertainty for patients and providers. The issue is expected to have significant consequences for the upcoming elections.